Bile acids are signaling molecules that play a critical role in regulation of hepatic metabolic homeostasis by activating nuclear farnesoid X receptor (Fxr) and membrane G-protein-coupled receptor (Takeda G-protein-coupled receptor 5; Tgr5). The role of FXR in regulation of bile acid synthesis and hepatic metabolism has been studied extensively. However, the role of TGR5 in hepatic metabolism has not been explored. The liver plays a central role in lipid metabolism, and impaired response to fasting and feeding contributes to steatosis and nonalcoholic fatty liver and obesity. We have performed a detailed analysis of gallbladder bile acid and lipid metabolism in Tgr5 2/2 mice in both free-fed and fasted conditions. Lipid profiles of serum, liver and adipose tissues, bile acid composition, energy metabolism, and messenger RNA and protein expression of the genes involved in lipid metabolism were analyzed. Results showed that deficiency of the Tgr5 gene in mice alleviated fasting-induced hepatic lipid accumulation. Expression of liver oxysterol 7a-hydroxylase in the alternative bile acid synthesis pathway was reduced. Analysis of gallbladder bile acid composition showed marked increase of taurocholic acid and decrease of tauro-a and b-muricholic acid in Tgr5 2/2 mice. Tgr5 2/2 mice had increased hepatic fatty acid oxidation rate and decreased hepatic fatty acid uptake. Interestingly, fasting induction of fibroblast growth factor 21 in liver was attenuated. In addition, fasted Tgr5 2/2 mice had increased activation of hepatic growth hormone-signal transducer and activator of transcription 5 (GH-Stat5) signaling compared to wild-type mice. Conclusion: TGR5 may play a role in determining bile acid composition and in fasting-induced hepatic steatosis through a novel mechanism involving activation of the GH-Stat5 signaling pathway. (HEPATOLOGY 2017;65:813-827) SEE EDITORIAL ON PAGE 767 B ile acids are signaling molecules that play a key role in regulation of metabolic homeostasis via activation of a nuclear bile acid receptor farnesoid X receptor (Fxr) and membrane G-proteincoupled bile acid receptor (Gpbar-1; aka Takeda G-protein-coupled receptor 5 [Tgr5]).
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Bile acids are signaling molecules that play a critical role in regulation of hepatic metabolic homeostasis by activating nuclear farnesoid X receptor (Fxr) and membrane G-protein-coupled receptor (Takeda G-protein-coupled receptor 5; Tgr5). The role of FXR in regulation of bile acid synthesis and hepatic metabolism has been studied extensively. However, the role of TGR5 in hepatic metabolism has not been explored. The liver plays a central role in lipid metabolism, and impaired response to fasting and feeding contributes to steatosis and nonalcoholic fatty liver and obesity. We have performed a detailed analysis of gallbladder bile acid and lipid metabolism in Tgr5 2/2 mice in both free-fed and fasted conditions. Lipid profiles of serum, liver and adipose tissues, bile acid composition, energy metabolism, and messenger RNA and protein expression of the genes involved in lipid metabolism were analyzed. Results showed that deficiency of the Tgr5 gene in mice alleviated fasting-induced hepatic lipid accumulation. Expression of liver oxysterol 7a-hydroxylase in the alternative bile acid synthesis pathway was reduced. Analysis of gallbladder bile acid composition showed marked increase of taurocholic acid and decrease of tauro-a and b-muricholic acid in Tgr5 2/2 mice. Tgr5 2/2 mice had increased hepatic fatty acid oxidation rate and decreased hepatic fatty acid uptake. Interestingly, fasting induction of fibroblast growth factor 21 in liver was attenuated. In addition, fasted Tgr5 2/2 mice had increased activation of hepatic growth hormone-signal transducer and activator of transcription 5 (GH-Stat5) signaling compared to wild-type mice. Conclusion: TGR5 may play a role in determining bile acid composition and in fasting-induced hepatic steatosis through a novel mechanism involving activation of the GH-Stat5 signaling pathway. (HEPATOLOGY 2017; 65:813-827) SEE EDITORIAL ON PAGE 767 B ile acids are signaling molecules that play a key role in regulation of metabolic homeostasis via activation of a nuclear bile acid receptor farnesoid X receptor (Fxr) and membrane G-proteincoupled bile acid receptor (Gpbar-1; aka Takeda G-protein-coupled receptor 5 [Tgr5]). (1, 2) Bile acids are synthesized from cholesterol exclusively in the liver, secreted into bile and stored in the gallbladder, and released to the intestinal tract for emulsifying fats and
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lipid-soluble vitamins. The classic bile acid synthesis pathway is initiated by cholesterol 7a-hydroxylase (Cyp7a1) for synthesis of two primary bile acids, cholic acid (CA) and chenodeoxycholic acid (CDCA). Sterol 12a-hydroxylase (Cyp8b1) is required for synthesis of CA, and sterol 27-hydroxylase (Cyp27a1) is involved in steroid side-chain oxidation. (3) In mouse liver, CDCA is 6b-hydroxylated to a-muricholic acid (a-MCA), which is epimerized to b-muricholic acid (b-MCA). The alternative bile acid synthesis pathway is initiated by Cyp27a1 and involves oxysterol 7a-hydroxylase (Cyp7b1). Bile acids are conjugated to the amino acids, taurine or glycine, before biliary secretion. In the intestine, conjugated CA and CDCA are deconjugated by bacterial bile salt hydrolases and then dehydroxylated by bacterial 7a-dehydroxylase to form deoxycholic acid (DCA) and lithocholic acid (LCA), respectively. Accumulation of high amounts of toxic bile acids could cause liver inflammation and injury and cholestatic liver diseases. Thus, bile acid synthesis is tightly regulated by bile acids returning from the ileum to hepatocytes to inhibit Cyp7a1 and Cyp8b1 gene transcription by two mechanisms. In the intestine, bile acids activate FXR to induce fibroblast growth factor 15 (Fgf15), which is circulated to the liver to activate membrane Fgf receptor 4 signaling to inhibit Cyp7a1 and Cyp8b1 gene transcription. In the liver, bile acids activate FXR to induce the negative receptor small heterodimer partner (Shp) to inhibit Cyp7a1 and Cyp8b1 gene transcription.
The liver plays a central role in lipid metabolism during fasting and refeeding cycles. During the postprandial state, the liver uptakes dietary fats to synthesize triglycerides for very-low-density lipoprotein (VLDL)-mediated secretion and transport to adipose tissue for storage and muscles for energy metabolism. During fasting, fatty acids are mobilized from adipocytes to the liver for energy metabolism. Prolonged fasting is known to induce hepatic steatosis and changes in endocrine and paracrine factors, such as thyroid hormone, insulin, glucagon, growth hormone (GH), and fibroblast growth factor 21 (Fgf21), and these hormones regulate hepatic glucose, lipid and energy metabolism, and maintain metabolic homeostasis. (4) (5) (6) The role of Fxr in regulation of metabolic homeostasis has been studied extensively. However, the role of Tgr5 in liver metabolism has not been explored. Tgr5 is expressed in many tissues, including intestine, gallbladder, liver, and brain. (7) (8) (9) (10) (11) In the liver, Tgr5 is expressed in Kupffer cells and sinusoidal endothelial cells, but not in hepatocytes. (10, 11) In the gastrointestinal tract, activation of Tgr5 by its specific agonists protects intestinal barrier function and inflammation, stimulates gallbladder refilling, and stimulates glucagon-like peptide 1 (GLP-1) secretion from enteroendocrine L-cells, (12) which stimulates insulin secretion from pancreatic b cells. (13) In brown adipocytes, activation of Tgr5 induces thyroid hormone deiodinase 2 (Dio2), which activates thyroid hormone to stimulate energy metabolism. (14) Secondary bile acids LCA and DCA are efficacious activators of Tgr5 to induce cyclic adenosine monophosphate and activate protein kinase A signaling pathways. (7, 8) Activation of Tgr5 by specific Tgr5 agonists has been shown to alleviate obesity and hepatic steatosis by maintaining glucose homeostasis in diet-induced obese mice. (15) However, Tgr5 deficient (Tgr5 2/2 ) mice do not have abnormal metabolic phenotypes (16) and are protected from lithogenicdiet-induced cholesterol gallstone formation. (17) Similar to Fxr 2/2 mice, Tgr5 2/2 mice have impaired liver regeneration, suggesting that both bile acid receptors are important in lipid metabolism during liver regeneration. (18) To understand the role of Tgr5 in liver lipid metabolism, we have performed a detailed analysis of bile acid and lipid metabolism in Tgr5 2/2 mice in both free-fed and fasted conditions. We hypothesized that Tgr5 might play a key role in bile acid synthesis and lipid
homeostasis. Our data show that gallbladder bile acid composition of Tgr5 2/2 mice was markedly altered. Surprisingly, we found that Tgr5 2/2 mice were protected from fasting-induced hepatic steatosis by reducing hepatic fatty acid uptake, and increasing hepatic fatty acid oxidation to ameliorate hepatic steatosis, likely through activation of a GH/signal transducer and activator of transcription 5 (Stat5) signaling.
Materials and Methods

ANIMAL EXPERIMENTS
Wild-type male C57BL/6J (WT) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and were maintained on regular chow diet and water ad libitum (unless specified) in a temperaturecontrolled facility with a 12-hour light/12-hour dark schedule (6:00 AM to 6:00 PM light). Tgr5 knockout (Tgr5 2/2 ) mice were obtained from Merck Research Laboratories (Kenilworth, NJ) and bred to a C57BL/ 6J background. Twenty-to 21-week-old WT mice (n 5 12) or Tgr5 2/2 mice (n 5 12) were separated to two groups (6 WT and 6 Tgr5 2/2 in each group). One group was free-fed chow diet and the other group was fasted for 24 hours. Mice were euthanized at noon, and tissues were collected and stored in 2808C until analysis. To study the role of the Janus kinase 2 (Jak2)/Stat pathway on hepatic lipid metabolism, mice were given a Jak2 inhibitor, tyrphostin Ag490 (5 mg/kg; Sigma-Aldrich, St. Louise, MO), or vehicle (phosphate buffered saline), intraperitoneally. Mice were fasted for 21 hours and were given a second dose of Ag490 (5 mg/kg) or vehicle and sacrificed 3 hours later. All animal experiments were performed at Northeast Ohio Medical University (Rootstown, OH), and protocols were approved by the institutional animal care and use committee.
HEPATIC b-OXIDATION RATE ANALYSIS
WT and Tgr5
2/2 male mice were fasted for 24 hours, euthanized, and livers were collected. Hepatic fatty acid oxidation rate was assessed using [1- 14 C] palmitic acid. (19) Intact mitochondria were isolated from mouse liver tissue using sucrose Tris-EDTA (ethylenediaminetetraactic acid) buffer. [ o C for 30 minutes, transferred to a new microcentrifuge tube with 200 lL of perchloric acid (1 M), and preincubated Whatman filter paper discs in the cap. Samples were incubated for 1 hour to entrap CO 2 released from the reaction mixture. After incubation, discs were transferred to scintillation vials and CO 2 released was analyzed using a scintillation counter. Microcentrifuge tubes were centrifuged at 14,000 rpm for 10 minutes, and 400 lL of supernatant was used to determine acid soluble metabolite (ASM) levels formed during reaction. Data generated are expressed in nmole/mg/min of palmitic acid converted to CO 2 and ASM.
HEPATIC FATTY ACID UPTAKE ANALYSIS
Hepatic fatty acid uptake assay was performed as described. (20, 21) WT and Tgr5 2/2 male mice were anesthetized with ketamine and xyalzine after overnight fasting.
3 H-labeled fatty acids (30 lCi, 3 H-oleic acid; Perkin-Elmer, Waltham, MA) were dissolved in 200 lL of BSA solution (2 mg/mL in saline), which was injected to mice by tail vein. At 1 and 10 minutes postinjection, mice were sacrificed and liver, skeletal muscle, adipose tissue, and blood were collected and radioactivity was determined using a scintillation counter. Radioactivity of liver was corrected for radioactivity present in serum during sampling and was normalized with tissue weight, whereas for skeletal muscle, radioactivity of tissue was normalized with tissue weight and expressed as percent of total radioactivity injected to each mice.
COMPREHENSIVE LABORATORY ANIMAL MONITORING SYSTEM
Comprehensive metabolic profiling of 20-to 21-week-old male WT and Tgr5 2/2 mice during 24-hour fasting was performed using an Oxymax lab animal monitoring system (Columbus Instruments, Columbus, OH). Respiratory exchange ratio, O 2 consumption, and CO 2 production, activity, and energy expenditure of mice were measured during 24-hour fasting.
STATISTICAL ANALYSIS
Statistical significance between groups was determined using one-way analysis of variance followed by a Turkey post-hoc test or t test, using GraphPad Prism software (GraphPad Software Inc., La Jolla, CA). Data are presented as mean 6 SE, with P 0.05 considered statistically significant.
Results
Tgr5
2/2 MICE WERE RESISTANT TO FASTING-INDUCED HEPATIC STEATOSIS
Prolonged fasting is known to induce hepatic steatosis by accumulation of adipose-tissue-derived free fatty acids (FFAs) in hepatocytes. (22) Extended fasting for 24 hours significantly decreased body weights in both WT and Tgr5 2/2 mice, but no significant change was observed between WT and Tgr5 2/2 mice after fasting (Supporting Fig. S1A ). No significant changes in liver weight were observed between free-fed and fasted WT mice, whereas liver weight in Tgr5 2/2 mice was significantly decreased after fasting (Supporting Fig. S1A ). White adipose tissue (epididymal fat) weight decreased in both fasted WT and Tgr5 2/2 mice (Supporting Fig. S1A ). Fasting did not affect serum triglyceride levels between WT and Tgr5 2/2 mice. Fasting increased serum FFA by 3-fold in WT mice, but Tgr5 2/2 mice had significantly lower circulating FFA compared to WT mice (Supporting Fig. S1B ). Serum cholesterol levels in Tgr5 2/2 mice were significantly higher compared to WT mice in both free-fed and fasted conditions (Supporting Fig. S1B ). Fasting induced serum b-hydroxybutyrate levels in both WT and Tgr5 2/2 mice by 10-fold compared to free-fed mice (Supporting Fig. S1B ).
Fasting significantly increased liver triglycerides and FFA levels in both WT and Tgr5 2/2 mice (Fig. 1A ). This effect was attenuated in fasted Tgr5 2/2 mice compared to fasted WT mice. Hepatic cholesterol levels showed a small, but significant, increase in fasted WT mice, but no significant change in Tgr5 2/2 mice. Hepatic glycogen content was significantly higher in free-fed Tgr5 2/2 mice compared to WT mice, indicating increased glucose storage as glycogen in Tgr5 2/2 mice, but no difference in fasted mice. Fasting significantly decreased hepatic glycogen content in both WT and Tgr5 2/2 mice. Oil Red O staining for neutral lipids (Fig. 1B) showed that fasting markedly increased lipids in WT mice, but Tgr5 2/2 mice had significantly lower lipid content. These results are surprising and may suggest that lack of Tgr5 protects the liver from fasting-induced hepatic steatosis. In white adipose tissue and skeletal muscle, triglyceride levels were decreased in fasted Tgr5 2/2 mice, but not WT mice (Fig. 1C,D) . FFAs were significantly decreased in skeletal muscle (Fig. 1D ), but not white adipose tissue (Fig. 1C) , of fasted Tgr5 2/2 mice.
Tgr5 2/2 MICE SWITCHED TO THE CLASSIC BILE ACID SYNTHESIS PATHWAY TO GENERATE A HYDROPHOBIC BILE ACID POOL
To understand the role of Tgr5 in bile acid metabolism, we analyzed hepatic bile acid synthesis gene expression and bile acid composition in gallbladder bile. Figure 2A shows that Cyp7a1 messenger RNA (mRNA) levels were the same in the fasted and freefed states in both WT and Tgr5 2/2 mice. Feeding should induce Cyp7a1 mRNA expression. (23) Unchanged Cyp7a1 expression in free-fed and fasted mice may be because mice were sacrificed at noon, the zenith of the Cyp7a1 circadian rhythm. In free-fed mice, Cyp7b1 and Cyp27a1 mRNA levels were significantly decreased in Tgr5 2/2 mice compared to WT mice, and fasting significantly decreased Cyp7b1 and Cyp27a1 expression in both WT and Tgr5 2/2 mice ( Fig. 2A) . Fasting induced Cyp8b1 mRNA in WT mice, as expected. (24) However, fasting induction of Cyp8b1 was significantly attenuated in Tgr5 2/2 mice compared to WT mice ( Fig. 2A) . We performed immunoblotting analysis to study whether changes of mRNA expression levels of Cyp7b1 and Cyp8b1 are consistent to their protein expression levels. Figure 2B showed that Cyp8b1 protein levels were induced by fasting in both WT and Tgr5 2/2 mice. Expression of Cyp7b1 is known to exhibit sexual dimorphisms, with higher expression in male than female rodents. (25) Fasting reduced Cyp7b1 protein levels in both WT and Tgr5 2/2 mice (Fig. 2B) , consistent with reduced Cyp7b1 mRNA levels by fasting. During fasting, bile acids are stored in the gallbladder and bile acid composition in bile represents de novo synthesized bile acids and bile acids circulated back to the liver by enterohepatic circulation. We therefore analyzed bile acid composition in gallbladder bile. Data showed a marked increase of TCA and TDCA and decrease of Ta-MCA and Tb-MCA in both free-fed and fasted Tgr5 2/2 mice compared to WT mice (Fig. 2C) . TCA, Bile acids are quantified as % of total bile acids analyzed (100%); <0.5% is rounded to 0. *Significant difference between FF and fasted condition (P < 0.05); # significant difference between WT and Tgr5 2/2 mice in either FF or fasted condition (P < 0.05). Abbreviations: GCA, glycocholic acid; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; THDCA, taurohyodeoxycholic acid; TLCA, taurolithocholic acid; TMDCA, tauromurideoxycholic acid; TUDCA, tauroursodeoxycholic acid.
TDCA, and Ta-MCA and Tb-MCA account for more than 90% of total bile acids in mouse bile. Other minor bile acid species were also increased in both free-fed and fasted Tgr5 2/2 mice. These changes in bile acid composition are consistent with decreased expression of Cyp7b1 in Tgr5 2/2 mice, indicating that the alternative bile acid synthesis was suppressed and the classic bile acid synthesis pathway was stimulated to produce more CA-and less CDCA-derived Tb-MCA. As a result, the hydrophobicity index of bile acid pool increased from -0.418 in WT mice to -0.22 in Tgr5 2/2 mice. The ratio of 12a-hydroxylated bile acids (TCA and TDCA) to non-12a-hydroxylated bile acids (TCDCA and Ta-MCA and Tb-MCA) increased from 0.71 in WT mice to 1.68 in Tgr5 2/2 mice. It is interesting to point out that bile acid composition seems to be dependent on genotype, and fasting/feeding does not affect bile acid composition, except that TDCA (%) increased 2-fold by fasting in both WT and Tgr5 2/2 mice. TDCA is a preferred ligand for TGR5, (8) indicating that TGR5 signaling may be stimulated in fasted mice.
Tgr5
2/2 MICE HAD INCREASED FATTY ACID OXIDATION
Fasting significantly decreased expression of lipogenic genes, such as Srebp-1, acetyl-CoA carboxylase alpha (Acc-a), Fasn, and Scd-1, in both WT and Tgr5 2/2 mice compared to free-fed mice (Fig. 3A) . Hepatic mRNA expression of Acc-a was increased 3-fold in free-fed Tgr5 2/2 mice compared to WT mice. Fasting increased hepatic carnitine palmitoyltransferase 1 a (Cpt1a), involved in fatty acid b-oxidation, and decreased Lpl expression in both WT and Tgr5 2/2 mice compared to free-fed mice (Fig. 3B) . Protein analysis showed significant increase in Cpt1 protein levels only in Tgr5 2/2 mice (Fig. 3B) , indicating increased hepatic fatty acid oxidation. Peroxisome proliferator-activated receptor a (Ppar-a) levels were not altered in either free-fed or fasted WT and Tgr5 2/2 mice. Ppar-gamma coactivator-1a (Pgc-1a) levels were induced in fasted WT mice and further increased in fasted Tgr5 2/2 mice (Fig. 3B ). Tgr5
2/2
mice had a significantly increased rate of palmitic acid oxidation to CO 2 and ASM compared to WT mice in the fasted condition (Fig. 3C) . Furthermore, expression levels of liver Fgf21 mRNA and serum Fgf21 were drastically induced during fasting in WT mice,
but were significantly lower in Tgr5 2/2 mice (Fig.  3D) . Given that hepatic autophagy plays an important role in lipolysis during fasting, (26) we analyzed expression of the hepatic autophagy marker, Lc3II, which increased 3.5-fold in fasted Tgr5 2/2 mice (Fig. 3E ).
Tgr5
2/2 MICE HAD ALTERED ENERGY EXPENDITURE
Given that Tgr5 is known to regulate energy metabolism and hormone levels, we analyzed serum hormone levels in fed and fasted mice. Tgr5 2/2 mice had increased serum insulin levels only during free-fed conditions and decreased thyroxin hormone levels only during fasting conditions compared to WT mice (Supporting Fig. S2A,B) . No significant difference in fasting glucagon levels was observed between WT and Tgr5 2/2 fasted mice (Supporting Fig. S2C ). To understand energy metabolism involved in attenuation of hepatic steatosis in Tgr5 2/2 mice, we examined respiratory exchange ratio, energy expenditure, and physical activity using the Comprehensive Laboratory Animal Monitoring System (Columbus Instruments). VO 2 and VCO 2 were significantly increased in fasted Tgr5 2/2 mice during both day and night compared to WT mice (Fig. 4A) . Although both VO 2 and VCO 2 are increasing in Tgr5 2/2 mice at both day and night times, respiratory exchange ratio (VCO 2 /VO 2 ) increased significantly only in daytime and significantly decreased in nighttime in Tgr5 2/2 mice compared to WT mice (Fig. 4B) . Energy expenditure was increased in fasted Tgr5 2/2 mice only during the night (Fig.  4C) . Physical activity was increased during both day and night in fasted Tgr5 2/2 mice compared to WT mice (Fig. 4D) . These data indicate that fasted Tgr5 2/2 mice are more active and used more lipids as an energy source (decreased respiratory exchange ratio) during the active period (night) compared to WT mice. These results are consistent with decreases in hepatic FFA and triglyceride levels and circulating FFA in fasted Tgr5 2/2 mice.
LACK OF Tgr5 SIGNALING IMPAIRED HEPATIC FATTY ACID UPTAKE
To determine whether attenuation of fastinginduced steatosis could be due to altered hepatic lipid uptake in Tgr5 2/2 mice, we analyzed hepatic fatty acid translocase (Cd36) and fatty acid transport protein (Fatp) mRNA levels. Fasting significantly increased hepatic Cd36 and Fatp4 mRNA levels in WT mice (Fig. 5A) . In Tgr5 2/2 mice, CD36 mRNA expression was reduced compared to WT mice in the free-fed state. Interestingly, hepatic Cd36 and Fatp4 mRNA levels were significantly down-regulated in fasted Tgr5 2/2 mice compared to fasted WT mice (Fig. 5A ). Fatp5 and Fabp1 mRNA levels were significantly decreased in fasted Tgr5 2/2 compared to WT mice. Western blotting analysis showed that Tgr5 2/2 mice had significantly decreased hepatic Cd36 protein levels in both fed and fasted conditions (Fig. 5B) . We further determined hepatic VLDL secretion and lipid uptake. Hepatic VLDL secretion was only significantly increased after 3 hours in Tgr5 2/2 mice compared to WT mice (Fig. 5C ). Fatty acid uptake assay showed significant decrease in hepatic fatty acid uptake in Tgr5 2/2 mice compared to WT mice at 1 and 10 minutes, but increased fatty acid uptake in skeletal muscle (Fig. 5D) . These results suggest that Tgr5 2/2 mice may have impaired hepatic fatty acid uptake, but increased fatty acid oxidation and VLDL secretion and increased fatty acid uptake into skeletal muscle to reduce hepatic triglyceride and FFA during fasting. (Fig. 6A) . Fasting significantly induced uncoupling protein 1 (Ucp-1) and Ucp-3 mRNA levels in WT mice compared to free-fed mice (Fig. 6A) . In Tgr5 2/2 mice, fasting significantly increased Ucp-2 mRNA levels compared to free-fed mice. In both WT and Tgr5 2/2 mice, fasting did not affect adipose tissue Ppar-c or its target genes, Cd36, Pgc-1a, and Fabp4, expression (Fig. 6A) . In fasted WT mice, Ucp-1, 2, and 3, Cpt1a, and Dio2 mRNA levels were increased in brown adipose tissue, indicating increase thermogenesis. However, fasting-induced increases of thermogenesis gene expression were lowered in fasted Tgr5 2/2 mice compared to fasted WT mice (Fig. 6B ).
FIG. 4. Effect of
Tgr5
2/2 MICE HAD INCREASED GH-Stat5 SIGNALING
It has been reported that Cd36 and hepatic steatosis are negatively regulated by GH-Stat5 signaling. (27) We analyzed p-Stat5 and Stat5 levels in WT and Tgr5 2/2 mice in fed and fasted conditions. Fasting significantly decreased the p-Stat5/Stat5 ratio in both WT and Tgr5 2/2 mice compared to free-fed mice. However, the p-Stat5/Stat5 ratio was significantly higher in 2/2 mice injected with 3 H-oleic acid. *Significant difference between FF and fasted condition (P < 0.05); # significant difference between WT and Tgr5 2/2 mice in either FF or fasted condition (P < 0.05). Abbreviations: AU, arbitrary units; Fabp1, fatty acid binding protein 1.
Tgr5
2/2 mice compared to WT mice in the fasting state (Fig. 7A) . Fasted Tgr5 2/2 mice have significantly higher nuclear Stat5 levels compared to WT fasted mice (Fig. 7B) . We also analyzed Ppar-c target genes involved in lipid droplet formation given that Stat5 activation is known to decrease Ppar-c target gene expression. (27) Hepatic aP2 (Fabp4) and cell-deathinducing Cidec mRNA levels were significantly downregulated in fasted Tgr5 2/2 mice compared to WT mice (Fig. 7C) . We also analyzed serum GH levels in these mice. Figure 7D shows that serum GH levels were markedly increased in both fasted WT and Tgr5 2/2 mice. However, Tgr5 2/2 mice have significantly higher serum GH levels than WT mice (Fig. 7D) . These results indicate that TGR5 signaling affects GH levels in both the fasting and free-fed state. However, Tgr5 2/2 mice may have activated hepatic GH-Stat5 signaling to reduce fatty acid transport to hepatocytes, thus reducing lipid droplets accumulation in Tgr5 2/2 mice during fasting. GH is known to activate the Jak2/Stat pathway. To further study the GHJak2/Stat pathway in hepatic lipid metabolism, we injected mice with a Jak2 inhibitor, Ag490, and fasted for 24 hours. Figure 7E showed that Ag490 significantly decreased hepatic triglycerides and FFAs in fasted WT mice, but did not further reduce hepatic 
lipids in fasted Tgr5
2/2 mice. Ag490 reduced p-Stat5 in hepatocytes (Supporting Fig. S3A ), tend to increase hepatic Cd36, Fgf21, and Cidec mRNA expression (Supporting Fig. S3B ), and increased phosphorylation of adipocyte HSL (Supporting Fig. S3C ). Thus, Ag490 may reduce adipocyte lipolysis, consistent with a report that deficiency of Jak2 impaired adipose lipolysis. (28) These results suggest that similar to adiposespecific Jak2 2/2 mice, increased GH in Tgr5 2/2 mice may also improve hepatic lipid metabolism in fasting.
Discussion
Detailed analysis of bile acid composition in Tgr5 2/2 mice revealed a significant increase in TCA and decrease in T-MCAs in bile, suggesting stimulation of the classic bile acid synthesis pathway and suppression of the alternative pathway. This is consistent with decreased expression of the key regulatory genes, Cyp27a1 and Cyp7b1, in the alternative bile acid synthesis pathway. Increasing TCA and decreasing TMCAs increased bile acid hydrophobicity indices in Tgr5 2/2 mice. In mice, TCA is the major Fxr ligand and tauro a/b-MCAs are potent Fxr antagonists. (29) This study suggests that Tgr5 may play an important role in altering bile acid composition in the bile acid pool and lowering of 12a-hydroxylated bile acids, the levels of which have been linked to insulin resistance in diabetic patients (30) and improving glucose sensitivity after vertical sleeve gastrectomy by modulating bile acid composition in circulating bile acids. (31) Recent studies show that activation of Fxr decreases fasting-induced hepatic autophagy, a key pathway involved in maintaining nutrient homeostasis during fasting. (32) The increase of hepatic Lc3II levels in Tgr5 2/2 mice may indicate increase of lipophagy to decrease hepatic triglyceride levels, (26) and increased Lc3II levels are correlated with increased GH-Stat5 activation. (33) During fasting, Tgr5 2/2 mice have increased hepatic Pgc-1a and Cpt1 and increased palmitic acid oxidation. Fasting increases FFA to stimulate Ppar-a activity and induce hepatic Fgf21 production. This study demonstrates a significant increase of Pgc-1a and decrease of hepatic Fgf21 production in Tgr5 2/2 mice. Pgc-1a is known to inhibit hepatic Fgf21 production, (34) and a recent study reports that Fgf21 inhibits hepatic GH-Stat5 signaling. (35) Therefore, reducing hepatic Fgf21 production stimulates hepatic Stat5 signaling in fasted Tgr5
The liver is a major target of GH action, and Stat5 signaling activates Jak2/Stat5 signaling to regulate fatty acid oxidation and steroid metabolism. (27) Mice expressing mutant GH receptor or deletion of Stat5 had increased hepatic Cd36 expression and hepatic steatosis when challenged with a high-fat diet. (27) Our study shows that Tgr5 2/2 mice have increased serum GH levels compared to WT mice. Chronic infusion of GH activates Ppar-a and prevents hepatic steatosis in diabetic rats. (36) It is possible that this GH-Stat5 mechanism may be activated in Tgr5 2/2 mice to stimulate hepatic lipolysis. Moreover, plasma GH levels show pulsatile secretion patterns in male rats, mice, and humans, but GH is constantly secreted at much lower levels in females. Pulsatile GH secretion results in sexual dimorphic expression of many male-specific liver genes, including Cyp7b1. (25) In hepatocytespecific Stat5-deficient mice, sexual dimorphic Cyp7b1 expression is reduced and hypophysectomy reduces Cyp7b1 expression. (25) Pulsatile infusion of GH to hypophysectomized mice increases Cyp7b1 expression, but continuous GH infusion for 5-7 days or disruption of GH pulsatile patterns decreases Cyp7b1 expression in WT male mice. (25, 37) It is interesting to note that high-fat-diet-fed female Tgr5 2/2 mice accumulated fat, gained weight, and had impaired insulin sensitivity, and male mice are not obese, but had increased steatosis. (16, 38) It is possible that GH signaling may play a role in sex-specific regulation of bile acid synthesis by Tgr5. Given that TGR5 is not expressed in hepatocytes, (10) TGR5 may regulate hepatic metabolism through paracrine or endocrine mechanisms. Bile acids have been detected in the brain. (39) TGR5 is expressed in the hypothalamus and may regulate neuroendocrine hormone secretions in cholestasis. (40, 41) It has been reported that the pituitary controls bile acid metabolism (42) and GH plays a role in regulation of bile acid synthesis. (43) Thus, bile acids may activate pituitary TGR5 to regulate GH secretion in the hypothalamus. Further studies are needed to explore the brain-to-liver axis in TGR5 regulation of liver bile acid metabolism.
It is interesting to point out that TGR5 has both a positive and negative effect in hepatic metabolism in fasting and feeding response and hepatic steatosis. Our current study shows that Tgr5 2/2 mice are protected against fasting-induced hepatic steatosis. Previous studies show Tgr5 2/2 mice are protected against lithogenic-diet-induced gallstone and insulin tolerance is improved in male Tgr5 2/2 mice on the chow diet, but impaired insulin sensitivity, when fed a high-fat diet. (17, 38) Tgr5 2/2 mice have increased serum GH, similar to adipose-specific Jak2 2/2 mice with high GH and reduced hepatic fatty liver. (28) On the other hand, postprandial activation of TGR5 by bile acids is known to improve insulin secretion from b-cells by stimulating GLP-1 secretion in enteroendocrine L cells, (12) whereas growth hormone counteracts insulin action in fasting. In this study, we report altered lipid metabolism in a model, which has no or low insulin signaling. Beneficial effects we observed during the fasting condition were attributed to lack of insulin signaling and increasing GH-Stat5 signaling. Lack of insulin signaling in the fasting condition is similar to diabetic condition. Figure 8 illustrates a mechanistic link of Tgr5 signaling to regulation of bile acid synthesis and lipid metabolism. Pulsatile GH secretion is known to activate Stat5 to induce male-specific Cyp7b1 expression in mice. High levels of serum GH in fed Tgr5 2/2 mice may inhibit Cyp7b1 in the alternative bile acid synthesis pathway and results in reducing TMCAs and increasing CA in bile acid pool. GH is known to stimulate lipolysis in adipose tissues and mobilize FFA.
In hepatocytes, GH activates the GH receptor, which recruits JAK2 to activate Stat5 by phosphorylation. In fasted Tgr5 2/2 mice, increased GH activates Stat5 signaling to decrease Cd36 expression and thus reduced FFA uptake into hepatocytes. FFA induces Pgc-1a, which increases fatty acid oxidation, but increase of Pgc-1a in Tgr5 2/2 mice dampens fasting-induced production of Fgf21, which is known to reduce hepatic Stat5 signaling and lipophagy to reduce hepatic steatosis in Tgr5 2/2 mice. Thus, lower Fgf21 levels may also stimulate hepatic Stat5 activation during fasting. This Cd36-Fgf21-Stat5 regulatory loop may be induced in fasting to regulate lipid metabolism.
In conclusion, deficiency of Tgr5 in mice alleviates fasting-induced hepatic steatosis by increasing hepatic lipolysis and GH-Stat5 signaling. This study uncovered a novel mechanism, that bile-acid-activated Tgr5 signaling may alter GH signaling and bile acid synthesis to regulate hepatic bile acid and lipid metabolism. Further study of GH-Stat5 signaling in Tgr5 2/2 mice is needed to understand the underlying mechanisms for increasing serum GH-Stat5 signaling during fasting, and for GH-Stat5 signaling in modulation of Cyp7b1 expression levels and bile acid metabolism.
FIG. 8.
Deletion of Tgr5 alters bile acid metabolism and alleviates fasting-induced hepatic steatosis by altering hepatic GHStat5 signaling. Pulsatile release of GH may activate Stat5 to induce male-specific Cyp7b1 expression and the alternative bile acid synthesis pathway. In Tgr5 2/2 mice, high levels of nonpulsatile GH secretion (GH resistance) may inhibit Cyp7b1 and Cyp27a1 to reduce CDCA and MCA synthesized by the alternative bile acid synthesis pathway and increase CA synthesis. In fasted Tgr5 2/2 mice, GH resistance activates Stat5 signaling to decrease Cd36 expression and uptake of FFAs into hepatocytes. FFAs induce Pgc-1a, which increases fatty acid oxidation, but increase of Pgc-1a in Tgr5 2/2 mice dampens fasting-induced Fgf21 production. Lower Fgf21 levels stimulate hepatic Stat5 activation and reduce hepatic steatosis. This Cd36-Fgf21-Stat5 regulatory loop may regulate lipid metabolism during fasting and feeding cycles. Abbreviations: GHR, growth hormone resistance.
